IC14 (Atibuclimab) in Arrhythmogenic Cardiomyopathy

Clinical trial NCT06275893 · COMPLETED

Trial details

NCT number: NCT06275893
Sponsor: Implicit Bioscience
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Arrhythmogenic Right Ventricular Dysplasia Arrhythmogenic Left Ventricular Cardiomyopathy Arrhythmogenic Right Ventricular Cardiomyopathy 1 Arrhythmogenic Cardiomyopathy ACM ARVC PKP2

Start date: 2024-03-29
Primary completion: 2025-08-15
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.